Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Evommune, Inc. | 5,288,313 | reported | 17 Feb 2026 | tx 6+5,288,313−27,168,477 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | GRANT_AWARD | Evommune, Inc. | 358,680 | 27.88 USD | |
| 07 Nov 2025 | CONVERSION | Evommune, Inc. | 3,367,133 | — | |
| 07 Nov 2025 | PURCHASE | Evommune, Inc. | 1,562,500 | 16.00 USD | |
| 07 Nov 2025 | CONVERSION | Evommune, Inc. | 5,090,000 | — | deriv |
| 07 Nov 2025 | CONVERSION | Evommune, Inc. | 15,493,466 | — | deriv |
| 07 Nov 2025 | CONVERSION | Evommune, Inc. | 6,585,011 | — | deriv |